Pinto Joshua 4

What Happened

• Joshua Pinto, President of Neumora Therapeutics (NMRA), disposed of 5,967 shares in an open-market/private sale on Feb 17, 2026 at $3.54 per share, generating approximately $21,093. The filing notes the sale was to satisfy tax-withholding obligations tied to the vesting of restricted stock units (RSUs), i.e., a sell-to-cover transaction rather than an active divestiture for liquidity/speculation.

Key Details

• Transaction date and price: Feb 17, 2026 — 5,967 shares sold at $3.54 each.
• Gross proceeds: ~$21,093.
• Transaction type/code: Sale (S); reason noted as tax withholding (F).
• Footnotes: F1 — sale to satisfy tax withholding on RSU vesting; F2 — shares held by Maple DE Holdings LLC.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Filing date/timeliness: Form 4 filed Feb 19, 2026 (appears timely under the two-business-day rule).

Context

• This was a routine sell-to-cover following RSU vesting, a common way insiders meet tax obligations and not necessarily a signal about the company's outlook. For retail investors, purchases often carry more informational weight than routine tax-related sales.